We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$160B
AUM Growth
-$3.45B
Cap. Flow
-$2.94B
Cap. Flow %
-1.84%
Top 10 Hldgs %
28.21%
Holding
7,551
New
501
Increased
2,626
Reduced
3,452
Closed
568

Sector Composition

Rank Sector Weight
1 Technology 7.7%
2 Healthcare 5.71%
3 Financials 4.62%
4 Consumer Discretionary 4.5%
5 Communication Services 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOMX
6401
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$3K ﹤0.01%
+1,127
New +$3.17K
OAK
6402
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$3K ﹤0.01%
67
-3,638,736
-100% -$187M
ATAXZ
6403
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$3K ﹤0.01%
+400
New +$3K
HHR
6404
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$3K ﹤0.01%
157
+118
+303% +$2.18K
ABUS icon
6405
Arbutus Biopharma
ABUS
$871M
$2K ﹤0.01%
1,083
-73,165
-99% -$126K
ACIU icon
6406
AC Immune
ACIU
$241M
$2K ﹤0.01%
484
ADAP
6407
DELISTED
Adaptimmune Therapeutics
ADAP
$2K ﹤0.01%
+1,643
New +$3.84K
AEG icon
6408
Aegon
AEG
$14B
$2K ﹤0.01%
397
-4,604
-92% -$18.3K
AQST icon
6409
Aquestive Therapeutics
AQST
$467M
$2K ﹤0.01%
811
+391
+93% +$1.47K
AR icon
6410
PUT
Antero Resources
AR
$10.9B
$2K ﹤0.01%
+600
New +$2.44K
BOTJ icon
6411
Bank Of The James
BOTJ
$125M
$2K ﹤0.01%
+118
New +$1.56K
EDZ icon
6412
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18.8M
$2K ﹤0.01%
5
GAU
6413
Galiano Gold
GAU
$468M
$2K ﹤0.01%
2,500
-99,524
-98% -$87.8K
GRVY
6414
GRAVITY
GRVY
$430M
$2K ﹤0.01%
69
GTES icon
6415
Gates Industrial Corporation Ltd.
GTES
$6.53B
$2K ﹤0.01%
213
-404,545
-100% -$3.97M
HTGC icon
6416
Hercules Capital
HTGC
$2.98B
$2K ﹤0.01%
140
-560
-80% -$7.31K
KODK icon
6417
Kodak
KODK
$819M
$2K ﹤0.01%
800
-21,823
-96% -$53.8K
LIT icon
6418
Global X Lithium & Battery Tech ETF
LIT
$1.53B
$2K ﹤0.01%
100
-56,470
-100% -$1.4M
NTCT icon
6419
CALL
NETSCOUT
NTCT
$2.91B
$2K ﹤0.01%
100
-900
-90% -$21.5K
SPNS
6420
DELISTED
Sapiens International
SPNS
$2K ﹤0.01%
+106
New +$1.85K
SWBI icon
6421
CALL
Smith & Wesson
SWBI
$669M
$2K ﹤0.01%
390
-13,921
-97% -$84K
UTI icon
6422
Universal Technical Institute
UTI
$2.21B
$2K ﹤0.01%
354
+314
+785% +$1.39K
VSH icon
6423
PUT
Vishay Intertechnology
VSH
$5.18B
$2K ﹤0.01%
100
VST icon
6424
PUT
Vistra
VST
$50.1B
$2K ﹤0.01%
65
WU icon
6425
PUT
Western Union
WU
$2.4B
$2K ﹤0.01%
100
-800
-89% -$17.3K

Similar funds

Barclays's Q3 2019 Portfolio in Review

As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.

  • Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
  • Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
  • Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
  • Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
  • Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
  • Barclays opened 501 new positions and closed 568 in Q3 2019.
  • Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.

Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.